The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York A Major Shift in Peptide Regulation Is Underway FDA to weigh easing limits on unproven peptides HRT & Peptide Therapy: Energy, Weight Loss & Balance FDA considers adding a dozen peptides to its bulk drug compounding list RAPS The Pharmacology of Longevity: Peptide Edition (Part 1)